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Abstract  
BACKGROUND: The incidence of infection and intestinal colonization with vancomycin resistant 
enterococci (VRE) is increasing in many countries in the last decade. Concerning the difficult 
antimicrobial treatment of infections caused by VRE, decreasing the incidence and prevalence of 
these infections is an important factor in VRE-induced morbidity and mortality control.  
AIM: To determine the prevalence of gastrointestinal colonization with vancomycin resistant 
enterococci in hospitalized and outpatients, and to determine the genetic base of the vancomycin 
resistance in VRE isolates. 
MATERIAL AND METHODS: Seven hundred and eighty stool specimens were investigated for the 
gastrointestinal carriage of vancomycin-resistant enterococci (VRE). Susceptibility to vancomycin 
was tested in all isolates by disk-diffusion test and E-test (AB Biodisk, Sweden). Determined 
vancomycin resistant enterococci were than tested for detection of vanA, vanB and vanC genes by 
PCR. 
RESULTS: Vancomycin resistant strains of enterococci were isolated from 46 (16.1 %) of the 285 
hospitalized patients and 5 (7.7 %) of the 65 patients living in the community (p < 0.05). The most of 
the highly resistant enterococci strains to vancomycin (95.2 %), were identified as E. faecium. 
Minimal inhibitory concentrations (MICs) to vancomycin in all 39 vanA genotypes of E. faecium and 
two vanA genotypes of E. fecalis were > 256 g/ml. Three vanB genotypes of E. faecium and one 
vanB genotype of E. faecalis had MICs of 32 g/ml. All six vanC genotypes of E. gallinarum had 
MICs of 8 g/ml. All vanA genotypes of VRE were highly resistant to vancomycin, with MICs above 
256 g/ml. Three vanB genotypes of VR E. faecium and one VR E. fecalis were resistant, with 
MICs 32 g/ml. vanC genotypes of VR E. gallinarum were intermediate resistant to vancomycin 
with MICs of 8 g/ml. 
CONCLUSIONS: The prevalence of vancomycin resistant enterococci in Republic of Macedonia 
was 2-fold higher in hospitalized than in outpatients. VanA genotype was dominant in isolates of E. 
faecium and it was highly associated with the MIC values above the 256 g/ml. Since most of the 
enterococcal infections are endogenous, there is a need for screening the colonization of patient’s 
intestinal flora with VRE at the hospital entry. Identification and genotyping of faecal enterococci, 
together with their susceptibility testing to vancomycin, could be useful marker for the infection 
control. 
 
 
 
 
Introduction 
 
Enterococci are inhabitants of the 
gastrointestinal tract which can colonize particular 
parts of the human body and cause: intra-abdominal 
infections, urinary tract infections, wound infections, 
endocarditis, bloodstream infections and sepsis [1-3]. 
Enterococci are quite resistant microorganisms, 
surviving in both animate and inanimate surfaces: 
bathroom sinks, thermometers, bed rails, night tables 
and other hospital equipment, for extended period of 
time [4]. This feature of enterococci increases their 
potential for spreading in the surrounding and for their 
transmition from person-to-person very easily. 
With the increasing resistance of enterococci 
to penicillins and aminoglycosides, the addition of 
resistance to vancomycin severely limitate therapeutic 
options for those persons who develop infections with 
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these highly resistant strains [5]. Many reports from 
different countries worldwide emphasize the rapid 
increase in the incidence of infection as well as 
colonization with vancomycin resistant enterococci 
(VRE) in the last five years [6]. Concerning the difficult 
antimicrobial treatment of infections caused by VRE, 
their decreasing is an important factor in VRE-induced 
morbidity and mortality control. It seems that the high 
rate of patient’s VRE colonization is an important 
factor in infection control. Many risk factors play an 
important role in colonization and infection with VRE: 
prolonged hospitalization, serious medical conditions, 
intensive care unit stays, abdominal and thoracic 
surgery, and urinary catheterization. Use of 
vancomycin, third generation of cephalosporins and 
antibiotics with anaerobic activity (imipenem, 
metronidazole and clindamycin) significantly associate 
with colonization and infection with VRE. Many 
studies have shown that intestinal colonization of VRE 
depends on geographic factors [7]. 
Since the prevalence of VRE as a health 
marker for infection control in hospitals has not been 
investigated in Republic of Macedonia, the objectives 
of the study was to determine the prevalence of 
gastrointestinal colonization with Vancomycin-
Resistant Enterococci in hospitalized and outpatients, 
and to determine the genetic base of the vancomycin 
resistance in VRE isolates. 
 
 
Material and Methods 
 
In a period of 3 months (August to October 
2013), the Laboratory for enteric infections at the 
Institute for Microbiology and Parasitology, Medical 
Faculty of the Ss Cyril and Methodius in Skopje, R. 
Macedonia, has received 585 stool specimens from 
patients between 40 and 70 years of age, hospitalized 
at the internal and surgery clinics, as well as clinic for 
infectious diseases. For each patient age, sex and 
length of hospital stay were recorded. In the same 
period, 195 stool specimens were received from the 
patients living in the community, with the same range 
of age as hospitalized patients. All 780 specimens 
were received for examination of bacteria as etiologic 
agents of gastrointestinal infections, and for 
investigation of the gastrointestinal carriage of 
vancomycin resistant enterococci (VRE). For that 
purpose specimens were inoculated on 5% sheep 
blood agar and incubated at 36-37
0
C for 24 hours in 
an aerobic conditions. Suspected colonies of 
enterococci were selected and identified by 
morphology and biochemical tests: catalase 
(negative) and esculin (positive) reaction.  
 
 
Susceptibility testing 
Initial susceptibility to vancomycin was tested 
by disk-diffusion test according to the 
recommendations of the National Committee for 
Clinical Laboratory Standards [8]. It was confirmed by 
E-test (AB Biodisk, Sweden). Bacterial suspensions of 
enterococci prepared with a turbidity-adjusted to 
achieve a final inoculum of 105 CFU/ml, were 
inoculated at Mueller-Hinton agar supplemented with 
5% sheep blood. They were incubated under the 
same conditions as during their initial isolation. The 
susceptibility of isolated enterococci to vancomycin 
was analysed according to the following criteria: MIC 
< 4 mg/ml was considered as sensitive to vancomycin, 
MIC between 4 and 16 mg/ml was considered as 
intermediate resistant to vancomycin, MIC equal or 
above 32 mg/ml was considered as resistant to 
vancomycin and MIC = 256 mg/ml was considered as 
highly resistant to vancomycin. Data were analyzed 
with SPSS (Version 13) software using chi-square 
test.  
 
DNA isolation 
Colonies of isolated enterococci were 
suspended in TEG buffer (25 mM Tris-HCl, 10 mM 
EDTA, 50 mM Glucose). A lysosime solution (10 
mg/liter)  was added and the mixture was incubated 
for 1 hour at 37
0
C. DNA was eluted with 10 mM Tris-
HCl (pH=8.0).  
 
PCR assay for vanA, vanB and vanC genes 
10 l of DNA was added to a 90 l PCR 
mixture containing 10 mM Tris-HCl (pH=8.0), 50 mM 
KCl, 2.5 mM MgCl2, 0.2 mM (each) the four 
deoxyribonucleotide triphosphates, 50 pmol of each 
primer from the three different primer couples (Table 
1) and 1.2 U of Taq DNA polymerase.   
Table 1:   Primers and expected PCR product sizes. 
Gene                                        Primer sequence                             Product size (bp) 
vanA – F                     5’ GGG AAA ACG ACA ATT GC 3’                          732 
vanA – R                     5’ GTA CAA TGC GGC CGT TA 3’ 
vanB – F                     5’ GTG ACA AAC CGG AGG CGA GGA 3’              433 
vanB – R                     5’ CGC CAT CCT CCT GCA AAA AA 3’ 
vanC – F                     5’ CTC CTA CGA TTC TCT TG 3’                            439 
vanC – R                     5’ CGA GCA AGA CCT TTA AG 3’ 
 
 
Amplification of DNA was performed in an 
Applied Biosystems thermocycler by using 
denaturation of DNA at 94
0
C for 2 minutes, followed 
by 30 cycles of 1 minute of denaturation at 94
0
C, 1 
minute of primers annealing at 54
0
C and 1 minute of 
extension at 72
0
C. Amplicons were analyzed by UV 
illuminator after running electrophoresis on a 1.5 % 
agarose gel containing 0.5 g/ml ethidium bromide.   
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Results  
 
One- hundred- twenty- nine (45.2 %) of the 
285 hospitalized patients and 19 (29.2 %) of 65 
patients living in the community carried enterococci in 
their gastrointestinal tract (p < 0.05). The mean age of 
the study participants was 53.6 (SD=25.2) years. 
58.5% of all participants were male. Fifty-two (40.3 %) 
out of 129 enterococci isolated from hospitalized 
patients and 6 (31.5 %) out of 19 enterococci isolated 
from outpatients respectively, were identified as 
Enterococus faecium (p < 0.01) (Table 2).  
Table 2: Distribution of Enterococcus spp. and E. faecium in 
hospitalized and outpatients. 
Number of patients 
No. and % of isolated 
Enterococcus spp. 
No. and % of 
Enterococcus isolates 
identified as E. faecium   
Hospitalized patients (285)   129/285       (45.2 %)       52/129            (40.3 %) 
Outpatients (65)     19/65         (29.2 %)         6/19              (31.5 %)  
Total No. of patients (350)   148/350       (42.3 %)      58/148             (39.2 %) 
 
 
Therefore, E. faecium was isolated from 52 
(18.2 %) out of 285 hospitalized patients and 6 (9.2 
%) out of 65 patients living in the community (p < 
0.05) (Table 3). Seventy-seven (59.7 %) out of 129 
enterococci isolated from hospitalized patients and 13 
(68.4 %) out of 19 enterococci isolated from 
outpatients belonged to Enterococcus fecalis and 
Enterococcus gallinarum. Enterococcus fecalis was 
identified in 56 (43.4 %) out of 129 isolates of 
enterococci from hospitalized patients, and in 10 (52.6 
%) out of 19 isolates of enterococci from outpatients. 
Enterococcus gallinarum was identified in 21 (16.3 %) 
out of 129 isolates of enterococci from hospitalized 
patients, and in 3 (15.8 %) out of 19 isolates of 
enterococci from outpatients (Table 3).  
Table 3: Distribution of three different species of enterococci in                          
hospitalized and outpatients. 
Number of patients E. faecium E. faecalis E. gallinarum 
Hospitalized patients    (285)  52/285     (18.2 %) 56/129    (43.4%) 21/129    (16.3 %) 
Outpatients  (65)   6/65        (9.2 %) 10/19      (52.6 %)   3/19      (15.8 %) 
Total No. of patients      (350)  58/350      (16.5 %) 66/148    (44.6 %) 24/148    (16.2 %) 
 
Vancomycin resistant strains of enterococci 
were isolated from 46 (16.1 %) of the 285 hospitalized 
patients, and 5 (7.7 %) of the 65 patients living in the 
community (p < 0.05). Forty (86.9%), 4 (8.69 %) and 2 
(4.34 %) vancomycin resistant isolates of E. faecium, 
E. gallinarum and E. fecalis respectively, belonged to 
the hospitalized patients. Two (40 %), 2 (40 %) and 1 
(20 %) vancomycin resistant isolates of E. faecium, E. 
gallinarum and E. fecalis, respectively, belonged to 
the patients living in the community (Table 4).  
According to the MICs, 97 (65.6 %) out of the 
148 enterococci isolated from both hospitalized and 
outpatients were susceptible to vancomycin (VSE), 
with MIC < 4 g/ml. Eighty-three (64.3%) out of 129 
VSE isolates belonged to hospitalized patients and 14 
(73.5 %) out of 19 VSE isolates belonged to 
outpatients.  In   51   (35.4 %)   out   of   148   isolated  
Table 4: Three different species of Vancomycin resistant 
enterococci (VRE) isolated from hospitalized and outpatients. 
 
Three different 
species of VRE  
VRE isolated from 
hospitalized patients 
No. and (%) 
VRE isolated from 
outpatients 
No. and (%)  
E. faecium 40         (86.9 %) 2          (40 %) 
E. gallinarum   4          (8.69 %)     2          (40 %) 
E. faecalis    2          (4.34 %) 1          (20 %) 
Total          46         (100.0 %)  5         (100 %) 
 
enterococci was detected resistance to vancomycin 
(vancomycin-resistant enterococci, VRE). On the 
basis of MICs, VRE isolates were separated into 3 
groups: 6 (11.76 %) revealed intermediate resistance 
to vancomycin (group 1), 4 (7.84 %) were resistant to 
vancomycin (group 2) and 41 (80.40%) were highly 
resistant to vancomicin (group 3) (Table 4). The most 
of highly resistant VRE (95.2 %) were identified as E. 
faecium, and the other 0.8 % belonged to E. faecalis. 
Three isolates of resistant VRE were E. faecium and 
only one E. faecalis. All intermediate resistant VRE 
were identified as E. gallinarum (Table 5).  
Table 5: MICs in three different Vancomycin Resistant 
Enterococcus (VRE) species. 
Three groups of 
VRE according 
their MICs to 
Vancomycin 
(g/ml) 
Three groups of 
VRE species 
    No       (%) 
 
E. faecium      
No       (%) 
 
E. faecalis   
No       (%) 
 
E. gallinarum  
No       (%) 
Group 1    (4 – 16)      6   (11.76 %) / / 6     (100 %) 
Group 2 (Above 
32) 
     4   (7.84 %)          3    (75 %)     1   (25 %) / 
Group 3 (Above 
256) 
   41   (80.4 %)        39   (95.2 %)     2   (0.8 %) / 
Total      51   (100 %)                            51   (100 %) 
 
Molecular analysis showed the presence of 
three genotypes of Enteroccocus: vanA, vanB and 
vanC (Fig. 1).  
 
 
Figure 1: Detection of vanA, vanB and vanC genes by PCR. (Lines: 
M -> PCR markers; Lines: 1, 2, 3,4, 5, and 6 -> vanB ; Line: 8 -> 
vanC; Lines: 10, 11, 12, 13, 14 and 15 -> vanA). 
 
Forty-one (80.4 %), 4 (7.8 %) and 6 (11.8 %) 
out of 51 VRE isolates has vanA, vanB and vanC 
genotype, respectively. VanA genotype was detected 
in 39 (92.85 %) out of 42 isolates of Enterococcus 
faecium, and 2 (66.6 %) out of 3 isolates of 
Enterococcus fecalis. VanB genotype was detected in 
3 (7.15 %) out of 42 isolates of E. faecium and 1 
(33.3%) out of 3 isolates of E. fecalis. VanC was 
detected in all 6 (100 %) isolates of E. gallinarum 
(Table 6). 
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Table 6: Three different genotypes in Vancomycin Resistant 
Enterococcus (VRE) isolates. 
van genotypes 
in VRE isolates 
van genotypes 
in VRE isolates 
No. and (%) 
E. faecium 
No. and (%) 
E. faecalis 
No. and (%) 
E. 
gallinarum 
No. and (%) 
vanA   41     (80.4) 39/42     (92.85)   2/3     (66.6) / 
vanB     4     (7.8)   3/42     (7.15)   1/3     (25) / 
vanC     6     (11.8) / /   6     (100) 
Total number of 
VRE isolates 
  51     (100) 51 (100) 
 
 
Minimal inhibitory concentrations (MICs) to 
vancomycin in all 39 vanA genotypes of E. faecium 
and 2 vanA genotypes of E. fecalis was > 256 g/ml. 
Three vanB genotypes of E. faecium and one vanB 
genotype of E. faecalis had MICs of 32 g/ml. All 6 
vanC genotypes of E. gallinarum had MICs of 8 g/ml. 
The risk factors which are associated with VRE 
colonization, included prolonged length of hospital 
stay (12.5 days vs. 7.6 days, p = 0.001) and higher 
age (63.8 years vs. 48.6 years, p = 0.002). 
 
 
Discussion 
 
The increasing incidences of colonization and 
infection with VRE have caused serious concern to 
physicians [9]. This study documents the prevalence 
of intestinal colonization in selected patients 
hospitalized at the internal clinics, surgical clinics, 
clinic for infective diseases, as well as patients living 
in the community (outpatients). Enterococci were 
found in 45.2 % of hospitalized patients and in 29.2 % 
of outpatients, and these results are in agreement with 
the findings in the literature [10]. E. faecium was 
isolated from 40.3 % of hospitalized and 31.5 % of 
outpatients, which is in agreement with previous 
findings of E. faecium [11]. In our study was not found 
significant difference between the prevalence of 
gastrointestinal tract colonization with E. faecium and 
E. fecalis in hospitalized patients, but the results have 
shown that E. gallinarum was significantly less 
common gastrointestinal tract colonizer in hospitalized 
patients (p < 0.05). In the group of outpatients was 
found the highest prevalence of gastrointestinal 
colonization with E. fecalis. The prevalence of VRE in 
hospitalized patients (16.1 %) was much higher than 
in outpatients (7.7 %) (p < 0.05). The rate of VRE 
colonization varies widely in different studies. The 
study of Gambarotto et al. showed the prevalence of 
VRE in hospitalized patients of 37 % [12], but in the 
study of Wisplinghoff et al. was shown that the 
prevalence of vancomycin resistant enterococci in 
hospitalized patients was 2 % and 60 % for E. fecalis 
and E. faecium, respectively [13]. The colonization 
level with VRE in outpatients from Europe parallels 
the colonization level of animals with this resistant 
microorganism [14]. We have no official data about 
the usage of vancomycin as a growth promoter in 
animals in the Republic of Macedonia, but on the 
bases of our findings regarding the low prevalence of 
VRE in outpatients with only 7.7 %, we can presume 
that it is not the case. n this study, we found a 
significant difference in the prevalence of particular 
species of VRE. The most prevalent species, with 
86.9 % in hospitalized patients, was E. faecium, 
against the prevalence of vancomycin resistant E. 
gallinarum and vancomycin resistant E. fecalis with 
8.69 % and 4.34 %, respectively (p < 0.05). These 
data agree with those found in the literature [15, 16]. 
Analyzing the genotypes in VRE, we found that the 
most prevalent genotype was vanA (80.4 %), against 
vanB and vanC genotypes, present in 7.8 % and 11.8 
% of VRE isolates, respectively. VanA genotype was 
dominant in isolates of E. faecium, presenting 39 
(92.85 %) out of 42 isolates. VanB genotype was 
detected in 3 and 1 isolate of E. faecium and E. 
fecalis, respectively. VanC was detected in all 6 
isolates of E. gallinarum.  Knowledge of the type of 
resistance is critical for infection control purposes. As 
transferable genes, vanA and vanB can spread from 
person to person and in that manner they can 
increase acquired resistance. Determination of the 
investigated VRE strains as vanA and vanB 
genotypes confirmed that the most isolates of VRE 
had acquired resistance. In contrast, taking in 
consideration that vanC genes are nontransferable 
and mediates low level of vancomycin resistance, they 
are not associated with serious infections and 
outbreaks and should not be considered important 
from an infection control point of view. Our findings of 
vanA and vanB genotypes resistancy agree with those 
found in the literature [17-19].  
In conclusion, this study shown that the 
prevalence of vancomycin resistant enterococci in R. 
Macedonia was 2-fold higher in hospitalized than in 
outpatients. This high rate of VRE colonization is an 
important factor in infection control. VanA genotype 
was dominant in isolates of E. faecium and it was 
highly associated with the MIC values above 256 
g/ml. Since most of the enterococcal infections are 
endogenous, there is a need for screening the 
colonization of patient’s intestinal flora with VRE at the 
hospital entry. Identification and genotyping of fecal 
enterococci, together with the investigation of their 
susceptibility to vancomycin, could be useful marker 
for the infection control.  
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